Filter
112
Filtered Results: 112
Text search:
M.
Vitoriaa
Featured
Recommendations
15
New Publications
23
Language
Document type
No document type
72
Guidelines
22
Studies & Reports
15
Fact sheets
2
Manuals
1
Countries / Regions
Eastern Europe
5
Russia
4
Ukraine
2
Armenia
2
Global
2
Latin America and the Carribbean
2
Western and Central Europe
2
Brazil
2
North Macedonia
1
Thailand
1
Estonia
1
Mozambique
1
Africa
1
Eastern Europe and Central Asia
1
North America
1
Belgium
1
Belarus
1
South Africa
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
HIV & STI
16
TB
3
Communicable Diseases
2
Hepatitis
2
NCD
2
Cardiovascular Diseases
2
Guidelines
2
Maternal Health
2
Paediatrics
1
Buruli Ulcer
1
Humanitarian Aid
1
COVID-19
1
Public Health
1
Sexual Violence
1
Pediatrics
1
Countries
1
Child protection
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
Humanitarian Crisis
1
Other
1
WASH
1
Gynaecology & Obstetrics
1
Neurology & Psychology
1
Water
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
12
HIV in Key Populations
12
TB/HIV Coinfection
11
Clinical Aspects, Treatment & Prevention
10
Transgender People
8
Treatment Guidelines HIV
6
ART Drug Resistance
5
General
5
Treatment & Prevention
4
Children & Adolescents
4
Drug resistance
4
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
4
HIV testing & services
3
Clinical Aspects
3
Opportunistic Infections
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Reports & Studies
3
Policies & Strategies
2
General Reports
2
TB & Drug Abuse
2
Prevention & Control
2
Eastern Europe
2
Men who have sex with men (MSM)
2
TB/HIV
2
Drug resistant TB
2
Neurological Disorders
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
TB/HIV Global
2
Latin America & the Carribean
2
Clinical Guidelines
2
HIV service delivery
2
Drugs
1
Public Health
1
Childhood TB
1
Background PTSD in children
1
Vaccines & Immunization
1
Yellow Fever
1
Violence & Protection
1
Adults
1
HIV surveillance
1
Prevention Guidelines
1
Schizophrenia
1
HIV testing & disclosure
1
Hepatitis
1
HIV
1
General Studies & Reports
1
Others
1
Prophylaxis
1
Vaccination
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Reports
1
Russia
1
Sex Worker
1
Manuals
1
Key Resources
1
Laboratory
1
Studies
1
Infection Prevention & Hygiene
1
COVID-19
1
Country Specific
1
For Migrants & Refugees
1
Country specific documents
1
Prison & Detention
1
Child Protection
1
Paediatrics
1
Children & Mental Health
1
Oxygen Therapy
1
Gambling
1
Community Health Workers CHW
1
HIV &TB
1
Epilepsy
1
Mental Disorders
1
Prevention & Measures
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Awareness
1
Clinical Aspects & Diagnosis
1
Armenia
1
General
1
Detection & Diagnosis
1
Policies and guidelines
1
Community Worker
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Nutrition
1
Research & Access
1
HIV and coinfection
1
WASH
1
Epidemiology
1
Depression
1
Eastern and Southern Africa
1
Cyclones Idai & Kenneth
1
Guidelines for national programmes and other stakeholders
世界卫生组织 结核菌/艾滋病病毒双 重感染防治政策指南
——适用于国家规划 和利益攸关方
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
Цель сборника – поделиться знаниями о нарушениях психического здоровья детей со специалистами, ежедневно занимающимися детьми и не имеющими медицинского образо...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
guidance for health managers, health workers, and activists
WHO clinical and policy guidelines
HIV i-Base
July 2018
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi...
Lancet. 2019; 394: 1212-1214
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
Mais pessoas morrem a cada ano de doenças cardiovasculares do que de qualquer outra causa. Mais de três quartos das mortes por doenças cardíacas e acidentes vasculares cerebrais ocorrem em países de baixa e média renda. A hipertensão - ou pressão alta - é uma condição médica grave que au...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
